Benzodiazepine-Refractory Status Epilepticus - Which Drug is Second-Line?

December 27, 2019 00:23:35
Benzodiazepine-Refractory Status Epilepticus - Which Drug is Second-Line?
Critical Care Perspectives in Emergency Medicine
Benzodiazepine-Refractory Status Epilepticus - Which Drug is Second-Line?

Dec 27 2019 | 00:23:35

/

Show Notes

Up to one-third of patients with status epilepticus will not respond to benzodiazepines.  Unfortunately, treatment of benzodiazepine-refractory status epilepticus is not well studied.  The longer seizures persist, the worse patients do.  In this podcast, we discuss the results of the recently completed ESETT trial that evaluated three anticonvulsant medications for status epilepticus.

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode 0

March 19, 2019 00:18:13
Episode Cover

BMV for ETI in the Critically Ill?

More than 1.5 million patients undergo endotracheal intubation each year in the U.S.  Endotracheal intubation can be complicated by hypoxemia, which is a known...

Listen

Episode 0

April 20, 2021 00:29:53
Episode Cover

The Physiologically Difficult Airway

Airway guru Dr. Ken Butler joins us for this podcast to discuss some great pearls and pitfalls in intubating patients with physiologic derangements that...

Listen

Episode 0

January 26, 2021 00:22:57
Episode Cover

The Critically Ill Patient with Aortic Stenosis

Patients with severe aortic stenosis who present with acute decompensated heart failure are among the most challenging patients to resuscitate.  In this podcast, we...

Listen